Can magnetic pulses calm the brain in PTSD and depression?
NCT ID NCT07327385
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how two types of noninvasive brain stimulation affect brain activity and the body's stress system in people with both PTSD and major depression. Fifty adults will receive both active and sham stimulation in random order, with brain and heart measurements taken right before and after each session. The goal is to understand how these treatments work, not to provide long-term relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults aged 18 to 65 years. 2. Clinical diagnosis of posttraumatic stress disorder (PTSD) according to DSM-5 criteria, confirmed by a board-certified psychiatrist. 3. Presence of comorbid major depressive disorder with stable clinical condition. 4. PTSD symptom severity defined as: PTSD Checklist for DSM-5, Chinese version (C-PCL-5) total score ≥ 31. 5. Depressive symptom severity defined as: Patient Health Questionnaire-9 (PHQ-9) total score ≥ 10. 6. Stable psychiatric medication regimen for at least 4 weeks prior to enrollment, or medication-free. 7. Ability to understand the study procedures and provide written informed consent. 8. Normal or corrected-to-normal vision and hearing. 9. Ability to comply with study procedures and visit schedule. Exclusion Criteria: 1. Lifetime diagnosis of schizophrenia spectrum disorders, bipolar disorder, or pervasive developmental disorders. 2. Alcohol or substance use disorder (excluding caffeine and nicotine) within the past 6 months. 3. Ongoing trauma-focused psychotherapy during the study period. 4. Prior exposure to repetitive TMS treatment exceeding five sessions. 5. Current or recent (within the past year) suicidal ideation or behavior, defined as: PHQ-9 item 9 score ≥ 1, confirmed by clinical psychiatric evaluation. 6. Self-injurious behavior requiring medical attention within the past 3 months. 7. History of epilepsy, seizure disorder, or family history of epilepsy. 8. Significant neurological disorders, severe traumatic brain injury, or history of brain surgery. 9. Presence of implanted metallic or electronic medical devices (e.g., pacemakers, cochlear implants, neurostimulators). 10. Uncontrolled major medical illnesses or severe cardiovascular disease. 11. Pregnancy or breastfeeding. 12. Skin lesions or infections at the stimulation site. 13. Use of medications known to significantly lower seizure threshold (e.g., tricyclic antidepressants or certain analgesics). 14. Any condition deemed by the investigator to render the participant unsuitable for rTMS.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression - major depressive disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tri-Service General Hospital
Taipei, Neihu, 114, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can brain stimulation rewire how depressed patients learn from rewards?
- Can ketamine boost mindfulness therapy for people facing pain and PTSD?
- Can lay workers in uganda talk depression down?
- Can a computer model outsmart depression in older adults?
- Can a single shot of ketamine calm suicidal distress in the ER?
- Can talk therapy mend more than mood in marital crisis?